May 08, 2025

FDA Warns Physicians of Tianeptine Dangers

The FDA warns physicians about unapproved tianeptine products that are linked to severe adverse events, including dependence, toxicity, and death.

Conexiant

May 08, 2025

Medical Oddities: Tummy Time for Grown-Ups

This week’s research: tattoos misfire, tea heals, and tummy time makes a comeback.

Conexiant

May 07, 2025

Dr. Vinay Prasad Shakes Up FDA Leadership

The FDA has appointed Vinay Prasad as its new vaccine chief, shaking up biotech stocks and signaling potential shifts in drug approvals.

Reuters

May 05, 2025

FDA Monthly Round-up: Key April Updates

April’s FDA approvals feature first-in-class therapies, targeted biologics, expanded indications, and innovative delivery systems across allergy, endocrinology, rheumatology, oncology, infectious diseases, and more.

Conexiant

May 01, 2025

FDA Approves Intranasal DHE for Acute Migraine Relief

The FDA has approved Atzumi for the acute treatment of migraine with or without aura in adults.

Conexiant

May 01, 2025

Discover the latest advancements and best practices in retina specialties at the global Retina World Congress.

Retinal Physician

May 01, 2025

Discover the latest advancements and best practices in retina medicine at the Retina World Congress, where leading experts gather to exchange cutting-edge research and innovative treatments.

Retinal Physician

May 01, 2025

Psilocybin Shows Promise for Parkinson's Disease

First clinical trial demonstrates psilocybin therapy significantly improves depression, anxiety, and motor symptoms.

Conexiant

May 01, 2025

Race, Sex Gaps Reshape Hearing Loss Landscape

A new study reveals significant disparities in hearing loss prevalence: 60.7% of White males are affected, compared with 29.2% of Black females.

Conexiant